Abstract
Hypertension significantly increases the risk of cardiovascular diseases and seriously affects people's health.The incidence of hypertension is rising rapidly in the world and hypertension has become a significant factor influencing the global average life expectancy.The diagnosis of hypertension is generally fulfilled by measuring diastolic and systolic blood pressure,but it is insufficient to differentiate essential hypertension from secondary hypertension,so it is crucial to identifying the cause of hypertension by detecting biomarkers in plasma.In clinical practice,five plasma biomarkers are utilized for diagnosing hypertension,and the detection tasks of a large number of cases have raised increasing demands for cost-effective,efficient,speedy,and diverse methods,which makes many traditional diagnostic technologies inadequate for meeting the needs of clinical diagnosis.The nanomaterial-based detection techniques have frequently attained the qualities of quick reaction,low cost,straightforward operation,high sensitivity,and strong specificity in recent years with the advancement of nanotechnology,so they have great potential for early and rapid diagnosis.In this review,we will introduce the characteristics and drawbacks of current clinical detection methods for hypertension screening,the principles and advancements of nanotechnology-based detection methods,as well as their potentials for clinical application.
基金项目
National Natural Science Foundation of China(22307028)
National Natural Science Foundation of China(82341044)
National Natural Science Foundation of China(22027810)
National Basic Research Program of China(2022YFA1603701)
National Basic Research Program of China(2021YFA1200900)
Strategic Priority Research Program of Chinese Academy of Sciences(XDB36000000)
Chinese Academy of Medical Sciences(CAMS)Innovation Fund for Medical Sciences(CIFMS 2019-I2M-5-018)
NETL
NSTL
万方数据